Deferred Tax Assets, Valuation Allowance of NORTHWEST BIOTHERAPEUTICS INC from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NORTHWEST BIOTHERAPEUTICS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • NORTHWEST BIOTHERAPEUTICS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $281,221,000, a 7.6% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NORTHWEST BIOTHERAPEUTICS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $281,221,000 +$19,776,000 +7.6% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $261,445,000 +$13,766,000 +5.6% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $247,679,000 +$12,455,000 +5.3% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q4 2021 $235,224,000 +$8,339,000 +3.7% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $226,885,000 +$19,197,000 +9.2% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $207,688,000 +$7,008,000 +3.5% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $200,680,000 +$22,025,000 +12% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $178,655,000 -$57,468,000 -24% 31 Dec 2017 10-K 02 Apr 2019 2018 FY
Q4 2016 $236,123,000 +$17,776,000 +8.1% 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q4 2015 $218,347,000 +$48,242,000 +28% 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q4 2014 $170,105,000 +$57,905,000 +52% 31 Dec 2014 10-K 16 Mar 2016 2015 FY
Q4 2013 $112,200,000 +$112,112,382 31 Dec 2013 10-K 17 Mar 2015 2014 FY
Q4 2012 $87,618* -$51,390,382 31 Dec 2012 10-K 01 Apr 2014 2013 FY
Q4 2011 $51,478,000 31 Dec 2011 10-K 08 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.